From the Wyss Institute, click to view this article on their website. New molecular strategy enriches multiple disease-related rare genetic…
Read More
NuProbe raised $11 million to continue development of ultra-sensitive, non-invasive blood test for the early detection of cancer and infectious diseases. The Series A funding was co-led by Sequoia China and Serica Partners.
